A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Thyroglobulin
Dimetindene
Lithium carbonate may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.
Thyroglobulin
Hexocyclium
Lithium carbonate may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.
Thyroglobulin
Mepenzolate
Lithium carbonate may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.
Thyroglobulin
Isopropamide
Lithium carbonate may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.
Thyroglobulin
Solifenacin
Lithium carbonate may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Thyroglobulin
Sodium chloride
Sodium chloride may increase the excretion rate of Lithium carbonate which could result in a lower serum level and potentially a reduction in efficacy.
Thyroglobulin
Potassium Iodide
Potassium Iodide may increase the hypothyroid activities of Lithium carbonate.
Thyroglobulin
(S)-Warfarin
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with (S)-Warfarin.
Thyroglobulin
Tioclomarol
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with Tioclomarol.
Thyroglobulin
Diphenadione
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with Diphenadione.
Thyroglobulin
Clorindione
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with Clorindione.
Thyroglobulin
Fluindione
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with Fluindione.
Thyroglobulin
Ethyl biscoumacetate
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with Ethyl biscoumacetate.
Thyroglobulin
(R)-warfarin
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with (R)-warfarin.
Thyroglobulin
Coumarin
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with Coumarin.
Thyroglobulin
4-hydroxycoumarin
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with 4-hydroxycoumarin.
Thyroglobulin
Brofaromine
The risk or severity of serotonin syndrome can be increased when Brofaromine is combined with Lithium carbonate.
Thyroglobulin
Harmaline
The risk or severity of serotonin syndrome can be increased when Harmaline is combined with Lithium carbonate.
Thyroglobulin
Caroxazone
The risk or severity of serotonin syndrome can be increased when Caroxazone is combined with Lithium carbonate.
Thyroglobulin
Safrazine
The risk or severity of serotonin syndrome can be increased when Safrazine is combined with Lithium carbonate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3